Breastfeeding, pregnancy, medicines, neurodevelopment, and population databases: the information desert.
Adverse drug reactions
Breastfeeding
Child development
Pharmacoepidemiology
Pharmacovigilance
Pregnancy
Journal
International breastfeeding journal
ISSN: 1746-4358
Titre abrégé: Int Breastfeed J
Pays: England
ID NLM: 101251562
Informations de publication
Date de publication:
02 08 2022
02 08 2022
Historique:
received:
22
06
2021
accepted:
27
06
2022
entrez:
1
8
2022
pubmed:
2
8
2022
medline:
4
8
2022
Statut:
epublish
Résumé
The pharmacoepidemiology of the long-term benefits and harms of medicines in pregnancy and breastfeeding has received little attention. The impact of maternal medicines on children is increasingly recognised as a source of avoidable harm. The focus of attention has expanded from congenital anomalies to include less visible, but equally important, outcomes, including cognition, neurodevelopmental disorders, educational performance, and childhood ill-health. Breastfeeding, whether as a source of medicine exposure, a mitigator of adverse effects or as an outcome, has been all but ignored in pharmacoepidemiology and pharmacovigilance: a significant 'blind spot'. WHY WE NEED THEM: Optimal child development and maternal health necessitate breastfeeding, yet little information exists to guide families regarding the safety of medicine use during lactation. Breastfeeding initiation or success may be altered by medicine use, and breastfeeding may obscure the true relationship between medicine exposure during pregnancy and developmental outcomes. Absent or poorly standardised recording of breastfeeding in most population databases hampers analysis and understanding of the complex relationships between medicine, pregnancy, breastfeeding and infant and maternal health. The purpose of this paper is to present the arguments for breastfeeding to be included alongside medicine use and neurodevelopmental outcomes in whole-population database investigations of the harms and benefits of medicines during pregnancy, the puerperium and postnatal period. We review: 1) the current situation, 2) how these complexities might be accommodated in pharmacoepidemiological models, using antidepressants and antiepileptics as examples; 3) the challenges in obtaining comprehensive data. The scarcity of whole-population data and the complexities of the inter-relationships between breastfeeding, medicines, co-exposures and infant outcomes are significant barriers to full characterisation of the benefits and harms of medicines during pregnancy and breastfeeding. This makes it difficult to answer the questions: 'is it safe to breastfeed whilst taking this medicine', and 'will this medicine interfere with breastfeeding and/ or infants' development'?
Sections du résumé
BACKGROUND
The pharmacoepidemiology of the long-term benefits and harms of medicines in pregnancy and breastfeeding has received little attention. The impact of maternal medicines on children is increasingly recognised as a source of avoidable harm. The focus of attention has expanded from congenital anomalies to include less visible, but equally important, outcomes, including cognition, neurodevelopmental disorders, educational performance, and childhood ill-health. Breastfeeding, whether as a source of medicine exposure, a mitigator of adverse effects or as an outcome, has been all but ignored in pharmacoepidemiology and pharmacovigilance: a significant 'blind spot'.
WHOLE-POPULATION DATA ON BREASTFEEDING
WHY WE NEED THEM: Optimal child development and maternal health necessitate breastfeeding, yet little information exists to guide families regarding the safety of medicine use during lactation. Breastfeeding initiation or success may be altered by medicine use, and breastfeeding may obscure the true relationship between medicine exposure during pregnancy and developmental outcomes. Absent or poorly standardised recording of breastfeeding in most population databases hampers analysis and understanding of the complex relationships between medicine, pregnancy, breastfeeding and infant and maternal health. The purpose of this paper is to present the arguments for breastfeeding to be included alongside medicine use and neurodevelopmental outcomes in whole-population database investigations of the harms and benefits of medicines during pregnancy, the puerperium and postnatal period. We review: 1) the current situation, 2) how these complexities might be accommodated in pharmacoepidemiological models, using antidepressants and antiepileptics as examples; 3) the challenges in obtaining comprehensive data.
CONCLUSIONS
The scarcity of whole-population data and the complexities of the inter-relationships between breastfeeding, medicines, co-exposures and infant outcomes are significant barriers to full characterisation of the benefits and harms of medicines during pregnancy and breastfeeding. This makes it difficult to answer the questions: 'is it safe to breastfeed whilst taking this medicine', and 'will this medicine interfere with breastfeeding and/ or infants' development'?
Identifiants
pubmed: 35915474
doi: 10.1186/s13006-022-00494-5
pii: 10.1186/s13006-022-00494-5
pmc: PMC9343220
doi:
Types de publication
Journal Article
Review
Research Support, Non-U.S. Gov't
Langues
eng
Sous-ensembles de citation
IM
Pagination
55Informations de copyright
© 2022. The Author(s).
Références
J Pregnancy. 2018 Nov 01;2018:4825727
pubmed: 30515328
Med Hypotheses. 2019 Jun;127:26-33
pubmed: 31088644
J Epidemiol Community Health. 2006 Jan;60(1):7-12
pubmed: 16361448
Cochrane Database Syst Rev. 2014 Oct 30;(10):CD010236
pubmed: 25354543
Arch Gen Psychiatry. 2003 Jul;60(7):720-6
pubmed: 12860776
Int Breastfeed J. 2020 Jun 17;15(1):57
pubmed: 32552911
Breastfeed Med. 2017 Apr;12:128-130
pubmed: 28394656
Eur Neuropsychopharmacol. 2016 Oct;26(10):1562-78
pubmed: 27568278
Int J Health Geogr. 2017 May 30;16(1):20
pubmed: 28558782
Arch Gynecol Obstet. 2014 Apr;289(4):755-63
pubmed: 24121691
Res Nurs Health. 2000 Oct;23(5):415-20
pubmed: 11052395
PLoS One. 2019 Nov 18;14(11):e0225133
pubmed: 31738813
Diabetes. 2015 Apr;64(4):1081-90
pubmed: 25805758
BJOG. 2005 Jul;112(7):927-34
pubmed: 15957994
Soc Sci Med. 2021 Jan;269:113592
pubmed: 33360022
Behav Sleep Med. 2016;14(1):5-22
pubmed: 25127316
Pediatr Int. 2015 Aug;57(4):546-51
pubmed: 25625700
BMJ. 2017 Mar 6;356:j832
pubmed: 28264803
Pharmacoepidemiol Drug Saf. 2019 Nov;28(11):1510-1518
pubmed: 31517430
Eur Neuropsychopharmacol. 2009 May;19(5):363-70
pubmed: 19223155
Epidemiology. 2021 Mar 1;32(2):194-201
pubmed: 33470711
Psychoneuroendocrinology. 2020 Mar;113:104581
pubmed: 31911347
Res Soc Work Pract. 2011 Nov;21(6):675-681
pubmed: 22675239
BMJ. 2022 May 3;377:e070113
pubmed: 35504648
Eur J Clin Pharmacol. 2020 Jan;76(1):107-115
pubmed: 31680189
JAMA Pediatr. 2014 Aug;168(8):729-36
pubmed: 24934501
PLoS One. 2021 Aug 27;16(8):e0256535
pubmed: 34449798
J Psychopharmacol. 2019 Nov;33(11):1340-1351
pubmed: 31304840
Lancet. 2006 Aug 19;368(9536):704
pubmed: 16920476
PLoS One. 2020 Dec 9;15(12):e0242489
pubmed: 33296383
Nutrients. 2019 Jul 21;11(7):
pubmed: 31330901
Lancet. 1998 Aug 8;352(9126):423-7
pubmed: 9708749
Neurosci Biobehav Rev. 2018 Feb;85:102-116
pubmed: 28472631
Breastfeed Med. 2017 May;12:199-201
pubmed: 28338339
J Perinatol. 2017 Sep;37(9):1003-1009
pubmed: 28682318
Am J Obstet Gynecol. 1993 May;168(5):1393-9
pubmed: 8498418
J Matern Fetal Neonatal Med. 2017 May;30(10):1189-1199
pubmed: 27379818
J Pers Soc Psychol. 1986 Dec;51(6):1173-82
pubmed: 3806354
Int J Obes (Lond). 2010 Sep;34(9):1371-80
pubmed: 20368710
Pharmacoepidemiol Drug Saf. 2019 Jul;28(7):906-922
pubmed: 31074570
Clin Pharmacol Ther. 2012 Apr;91(4):692-9
pubmed: 22398969
Curr Environ Health Rep. 2016 Sep;3(3):287-301
pubmed: 27344145
Schizophr Res. 2016 Oct;176(2-3):349-356
pubmed: 27484686
J Epidemiol. 2020 Sep 5;30(9):377-389
pubmed: 32684529
Am J Epidemiol. 2004 Apr 15;159(8):721-31
pubmed: 15051581
Pediatrics. 2016 Dec;138(6):
pubmed: 27940699
Nat Commun. 2020 Nov 12;11(1):5749
pubmed: 33184277
Endocrinology. 2018 Aug 1;159(8):2850-2862
pubmed: 29893816
PLoS One. 2013 Jul 09;8(7):e67912
pubmed: 23874465
J Epidemiol Community Health. 2011 Apr;65(4):297-300
pubmed: 20696848
J Epidemiol Community Health. 2015 Sep;69(9):826-33
pubmed: 25911693
Scand J Public Health. 2001 Dec;29(4):300-7
pubmed: 11775787
Clin Pharmacol Ther. 2020 Nov;108(5):964-970
pubmed: 32378749
Clin Pharmacol Ther. 2016 Jul;100(1):42-52
pubmed: 27060684
J Affect Disord. 2020 Jul 1;272:363-370
pubmed: 32553379
Int J Epidemiol. 2013 Feb;42(1):97-110
pubmed: 22507742
Struct Equ Modeling. 2020;27(2):318-329
pubmed: 32774078
Int J Epidemiol. 2010 Apr;39(2):417-20
pubmed: 19926667
Environ Health Perspect. 2010 Oct;118(10):1429-33
pubmed: 20562055
BJOG. 2016 Nov;123(12):1908-1917
pubmed: 26374234
Breastfeed Med. 2021 Jan;16(1):5-7
pubmed: 33237799
Drug Saf. 2022 Apr;45(4):333-344
pubmed: 35357659
Drug Saf. 2018 Jan;41(1):87-94
pubmed: 28840499
Am J Public Health. 2018 May;108(5):616-619
pubmed: 29565659
Diabetes Care. 2017 Jul;40(7):920-927
pubmed: 28487451
J Hum Lact. 2012 May;28(2):181-8
pubmed: 22344850
Annu Rev Public Health. 1997;18:341-78
pubmed: 9143723
Epidemiology. 2014 May;25(3):418-26
pubmed: 24713881
Annu Rev Sociol. 2014 Jul;40:31-53
pubmed: 30111904
Ann Stat. 2013 Feb;41(1):196-220
pubmed: 25544784
Clin Pediatr (Phila). 2016 Mar;55(3):236-44
pubmed: 26170275
Prog Neuropsychopharmacol Biol Psychiatry. 2021 Apr 20;107:110228
pubmed: 33358964
Am J Epidemiol. 2016 Aug 15;184(4):315-24
pubmed: 27489089
J Epidemiol. 2020 Apr 5;30(4):153-162
pubmed: 32009103
Int Breastfeed J. 2012 Oct 17;7(1):14
pubmed: 23072595
J Clin Med. 2019 Feb 08;8(2):
pubmed: 30744008
BMJ Open. 2018 Sep 5;8(9):e023090
pubmed: 30185579
Birth Defects Res. 2017 Jul 17;109(12):909-923
pubmed: 28714603
Lancet. 2016 Jan 30;387(10017):475-90
pubmed: 26869575
Lancet. 2014 Jul 12;384(9938):189-205
pubmed: 24853593
Int Breastfeed J. 2015 Oct 28;10:28
pubmed: 26516340
J Chronic Dis. 1979;32(1-2):51-63
pubmed: 447779
Eur J Clin Pharmacol. 2014 Nov;70(11):1361-6
pubmed: 25183382
Neurobiol Sleep Circadian Rhythms. 2020 Jul 06;9:100053
pubmed: 33364522
Environ Res. 2021 Jan;192:110199
pubmed: 32941839
Lancet. 1982 Oct 23;2(8304):937
pubmed: 6126782
Pediatrics. 1994 Jan;93(1):137-50
pubmed: 8265310
Acta Obstet Gynecol Scand. 2022 Mar;101(3):344-354
pubmed: 35170756
Obes Rev. 2015 Aug;16(8):621-38
pubmed: 26016557
Pediatr Res. 2017 Mar;81(3):434-442
pubmed: 27846197
Can Med Assoc J. 1985 Apr 15;132(8):933, 936
pubmed: 3919914
Semin Perinatol. 2020 Apr;44(3):151224
pubmed: 32199600
PLoS One. 2015 Nov 13;10(11):e0142861
pubmed: 26566028
JAMA. 2017 Apr 18;317(15):1553-1562
pubmed: 28418479
Epidemiology. 2000 Sep;11(5):550-60
pubmed: 10955408
Am J Public Health. 1987 Oct;77(10):1294-7
pubmed: 3115123
Environ Sci Pollut Res Int. 2019 Mar;26(8):7405-7427
pubmed: 30687894
BMC Med. 2018 Jan 15;16(1):6
pubmed: 29332605
Eur J Clin Pharmacol. 2009 Aug;65(8):839-46
pubmed: 19365629
JAMA Neurol. 2020 Apr 1;77(4):441-450
pubmed: 31886825
BJOG. 2009 Nov;116(12):1622-9; discussion 1630-2
pubmed: 19735379
Int J Epidemiol. 2018 Feb 1;47(1):226-235
pubmed: 29040562
Pharmacogenomics. 2014 May;15(7):1029-41
pubmed: 24956255
J Hum Lact. 2010 May;26(2):187-95
pubmed: 19652194
J Hum Lact. 1999 Dec;15(4):347-9
pubmed: 10776186
JAMA Neurol. 2013 Nov;70(11):1367-74
pubmed: 24061295
Nutr Neurosci. 2019 May;22(5):354-362
pubmed: 29046132
Clin Toxicol (Phila). 2012 Jun;50(5):390-5
pubmed: 22537257
Eur J Epidemiol. 2017 Sep;32(9):797-805
pubmed: 28929268
Clin Epidemiol. 2017 Mar 31;9:195-204
pubmed: 28408854
JAMA Pediatr. 2013 Sep;167(9):836-44
pubmed: 23896931
Br J Clin Pharmacol. 2020 Aug 29;:
pubmed: 32860456
Int J Environ Res Public Health. 2021 Apr 06;18(7):
pubmed: 33917424
FASEB J. 2003 Apr;17(6):699-701
pubmed: 12586743
BMJ. 2020 Nov 25;371:m4075
pubmed: 33239272
Drug Saf. 2018 Sep;41(9):829-833
pubmed: 29714003
Pharmacoepidemiol Drug Saf. 2018 Feb;27(2):148-160
pubmed: 29285840
Asian J Psychiatr. 2020 Feb;48:101916
pubmed: 31923810
J Clin Endocrinol Metab. 2010 Feb;95(2):837-46
pubmed: 19965920
Int J Environ Res Public Health. 2019 Apr 23;16(8):
pubmed: 31018505
Int Breastfeed J. 2020 Jun 15;15(1):55
pubmed: 32539791
BMC Med Inform Decis Mak. 2020 Dec 11;20(1):333
pubmed: 33308213
Cancer Epidemiol. 2018 Apr;53:49-55
pubmed: 29414632
Arch Gen Psychiatry. 2008 May;65(5):578-84
pubmed: 18458209